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ABSTRACT
Over time, “superbugs,” or bacteria that have become resistant to antibiotics, have
become a great concern in modern medicine. Viable alternates are currently being looked into as
effective and safe ways to prevent or treat infections caused by these superbugs. One such
method is through the utilization of the second messenger molecule cyclic-di-GMP (c-di-GMP)
that has been shown to regulate phenotypes within other bacteria that may control surface
colonization in Acinetobacter baumannii. Through a series of experiments, the active enzymes
that create c-di-GMP - diguanylate cyclases - and break down c-di- GMP - phosphodiesterases have been inactivated in mutants to test phenotypes including biofilm formation, motility,
antibiotic resistance, and desiccation survival. The research’s objective is to show that
manipulation of c-di-GMP within the multi-drug resistant strain of Acinetobacter baumannii may
serve as a means to control this bacteria.
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INTRODUCTION
Discovery of cyclic-di-GMP:
Cellulose, or poly-b-D-glucose is one of the most abundant biopolymers found across
the world [8]. Most people already know that cellulose is found in plants; however, it has been
found that some bacteria may also be capable of producing this biopolymer. The enzyme
cellulose synthase, the enzyme responsible for cellulose synthesis, may have originated from
cyanobacteria that has been postulated to form the symbiotic relationships with plants and is now
the organelle chloroplast. Studies conducted by Manfred Aschner and Shlomo Hestrin at the
Hebrew University of Jerusalem looked into the production of pure microcrystalline cellulose
fibers from Komagataeibacter xylinus, an alpha-proteobacteria. Isolation of the cellulose
synthase enzyme was attempted, but was determined that the enzyme required membrane-bound
and soluble components to become active. Benziman and his colleagues were in search of the
conditions that would activate cellulose synthase. It was his group that found that a Guanosine
Triphosphate analog, guanosine 5’-[gamma-thio]triphosphate], was an effective stimulator to this
enzyme. This was their key that lead them to be able to solubilize active cellulose synthase
complexes that compared catalytically to a whole cell form. Once this was found, they set out to
determine the structure of the activating factor. They had prior knowledge that it was a cyclic
structure with a 3’ to 5’ bond. They soon found this molecule to be c-di-GMP as the activator
factor. Benziman soon went on to find the GGDEF and EAL domains, which are diguanylate
cyclases and phosphodiesterases involved in c-di-GMP turnover. These domains, along with
curli fimbriae, played a key role in biofilm formation in other bacterial species such as
Salmonella Typhimurium, Escherichia coli, Citrobacter, Enterobacter, and Klebsiella genera.
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Mechanisms of cyclic di-GMP regulation:
Since Benziman’s work, it has become more apparent that c-di-GMP plays a crucial role
in the bacterial life cycle, as well as the virulence properties they possess that allow them to
persist in today’s world [8]. In addition, this signaling molecule is rudimentary to other important
pathways such as quorum sensing and phosphorylation pathways. C-di-GMP consists of two
GMP moieties bound by a 5’-3’ cyclic ring and is one of the most well understood and
researched cyclic dinucleotides. C-di-GMP levels within bacteria are controlled by both internal
and environmental cues. This control is provided by the activity of two enzymes within the
bacterium. These enzymes, diguanylate cyclases (DGCs) and c-di-GMP-specific
phosphodiesterases (PDEs), can be found in all of the major bacterial phyla showing its
prevalence as signaling proteins in the bacterial kingdom. The GGDEF domains of the DGCs
arrange with one GTP, and dimerization allows them to perform condensation to create the c-diGMP molecule. The EAL domain, which relates to the PDEs, is responsible for the hydrolysis of
c-di-GMP to yield a linear pGpG molecule that is eventually broken down to two GMPs.
Dimerization of these proteins are orchestrated by the N-terminal sensory domains. This would
explain why so many different proteins are present within the genome.
C-di-GMP generates phenotypic changes through interaction with c-di-GMP-binding
effectors that include transcriptional regulators, mRNA riboswitches, proteins that contain either
GGDEF or EAL non-enzymatic domains, and proteins that contain a PilZ domain. Phenotypes
regulated by c-di-GMP vary among bacterial species, but the motile-sessile transition and
biofilm formation is a broadly conserved feature of c-di-GMP. Typically, it is shown that low
levels of c-di-GMP are associated with motility, while the reverse can be said for biofilm
formation and production. However, this system does not simply work as a “on/off” switch
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within the bacteria. Motility and biofilm formation are regulated through various mechanisms
depending on the bacteria of study. For instance, in E. coli and Salmonella Typhimurium
increased levels of c-di-GMP interferes with both rotor-stator interface and the c-di-GMPbinding flagellar brake YcgR. Motile conditions activate PDEs to increase their affinity to c-diGMP, permitting degradation and allowing effectors to increase motility. In terms of biofilm
formation, bacteria can change their behavior when in contact with a surface. They begin
exposing adhesins and producing an extracellular matrix to protect themselves. This behavior
can be controlled by c-di-GMP at various levels within the cell. In addition, it is important to
note that the gammaproteobacterial relative of Acinetobacter baumannii, Pseudomonas
aeruginosa, exhibits isolates from human patients with cystic fibrosis showing mutations that
lead to the upregulations of DGCs [8,10]. The use of second messenger molecules is a pretty
straightforward system when compared to the protein-protein interactions that take places in a
cell [8]. It is also easy, from an evolutionary standpoint, to incorporate changes into that system.
While research on how c-di-GMP is incorporated into other pathways such as quorum sensing
and phosphorylation continues, overlap of these systems suggests a broad role for c-di-GMP in
bacterial signaling. Several bacterial virulence factors have been shown to be tied to c-di-GMP
levels, indicating that modulation of c-di-GMP levels may show promise in possible future
treatments of patients.
Acinetobacter baumannii:
Acinetobacter baumannii is a Gram-negative bacillus [1]. It is an anaerobic, nonflagellated organism that is typically found within water and the soil. Due to the introduction of
the notorious antibiotic penicillin by Alexander Fleming, people began treating everything with
penicillin [6]. However, due to the over use of antibiotics throughout time since its discovery, it
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has expedited the process in which bacteria handle medications. Acinetobacter baumannii has
developed tactics such as porins, b-lactamase, modifications of aminoglycosides, upregulation of
efflux pumps, and so much more in order to protect itself from antibiotics [10]. Today, A.
baumannii is also a common nosocomial infection that produces resilient biofilms on many
surfaces within hospitals [1]. Biofilm formation can take place on ventilators and catheters.
Immunocompromised people and those with open wounds from surgery can be at serious risk if
infected with this opportunistic, multi-drug resistant pathogen. Due to its virulence properties, it
can persist and survive in a hospital environment despite the sterilization methods that take place
to combat this pathogen. In addition, Acinetobacter has been nicknamed the “Iraqibacter” due to
its infection of United States Military members in Iraq and Afghanistan. Due to strains of this
organism developing multi-drug resistance, having the ability to effectively produce biofilms
within hospital environments, and be an opportunistic pathogen, controlling the second
messenger molecule cyclic di-GMP in order to control the virulence factors in Acinetobacter
baumannii can be a new way to prevent nosocomial infections within the human population.
BACKGROUND
The mutants and their domains:
Previous work has been done with c-di-GMP and Acinetobacter baumannii. Moriah
Arnold, Dr. Erik Petersen, and their colleagues have done a series of experiments with a multidrug resistant clinical isolate (UW5075). They worked with transposon mutants deleted for each
of the DGC- or PDE-encoding genes. Below, Figure 1 shows the mutants that correspond with
diguanylate cyclase mutants.
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Figure 1: Diguanylate cyclase only proteins within Acinetobacter baumannii. Blue bars indicate transmembrane
domains. PAC domains are sensory domain components.

In theory, knocking these GGDEF protein domains out will limit the production of c-diGMP. However, some proteins contain both a GGDEF and an EAL domain. These both possess
DGC and PDE activity regulated by their sensory domains.

Figure 2: Dual DCG and PDE domains within A. baumannii proteins. PAS domains are sensory domains.

In continuation, we come to two strains with degenerate domains. In these cases, the
active site residues within the protein have been mutated, but these domains may retain the
ability to bind c-di-GMP or act in some other regulatory role. While both appear to contain both
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GGDEF and EAL domains, in 1221 the EAL domain is predicted to be active but the GGDEF
domain may be inactive due to mutations within the active site. Further, 1138 is inactive at its
EAL domain and it is questionable if a GGDEF domain is even present.

Figure 3: A. baumannii proteins containing degenerate enzymatic domains.

Lastly, the 2255 mutant, as shown in figure 4, does not have a DGC or PDE domain but
instead has a PilZ domain. As mentioned before, PilZ is a c-di-GMP-binding domain and is
responsible for type IV pili motility in other organisms.

Figure 4: PilZ domain.

Figures 1-4 are used for a better understanding of which phenotypes will be expected of
each mutant.
Biofilm assay:
For the biofilm assay, cell cultures were diluted to an 0.05 optical density in lysogeny
broth [3,11]. 200 microliters were then placed in a 96 well plate and grown overnight without
shaking. They form a barrier along the interface of the water and air to adhere to the plastic.
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Excess culture was removed and washed. Crystal violet was used to stain. After additional
washing to remove the crystal violet stain, 100% ethanol was added to dissolve the crystal violet
and mixed well. Then the intensity of the crystal violet was measured at 590 nanometers and
converted in terms of the wild type. As shown in the figure below, our mutants who showed
statistical significance were 0137, 1221, and 3354 and had lower levels of biofilm formation. In
this case, it is most likely that their protein domains are behaving has DGCs. If this is the case,
cyclic-di-GMP levels will decrease and lead to the inhibition of biofilm production and stimulate
motility.

Figure 5: Relative biofilm formation of the A. baumannii mutants.

Twitching Motility:
An agar plate was made with a higher water to agar ratio to allow a more liquified plate
[3,11]. Then one microliter of 1.0 OD600 cell culture was stabbed in the center of the plate and
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incubated at 37oC. A. baumannii is able to twitch along the lower surface of the agar at the
plastic interface, generating a circular zone. Distance was then measured in centimeters and put
in terms to the wild type.

Figure 6: Twitching Motility Plates

The above figure shows that mutants 1221 and 2255 showed severe decrease in motility.
In the case of 1221, the protein domain must be acting as a PDE since it is categorized as a dual
or only EAL domain. 2255 is the PilZ domain which would conclude why motility decreases.
Rifampicin Assay:
The next assay is determination of the minimum inhibitory concentration (MIC) [3,11].
Very few antibiotics are effective due to this being the hospital isolate strain. However, some
mutants showed increased resistance to rifampicin, including 0137. Overnight cultures were
diluted to 0.05 OD600 and were grown overnight in a 96 well plates. Eleven different two-fold
dilutions of rifampicin took place while a twelfth one had no antibiotic. Measurements of relative
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optical density compared to the non-treated well was how results was recorded. It was shown
that the mutant 0137 grew better with rifampicin when compared to the wild type.

Figure 7: MIC of Rifampicin

MATERIALS AND METHODS
Collection of domain images:
The visual images collected above (Figure 1-4) for the different domains of the mutant
knockouts was compiled through use of the Prokaryotic Genome Analysis Tool (PGAT) and the
protein database of Simple Modular Architecture Research Tool (SMART) websites [12,13].
Mutants’ identification credentials were used on PGAT in order to find the protein sequence.
Once the protein sequence was retrieved, it was put into the SMART protein database in order to
produce the visual aids.
Desiccation Assay:
The desiccation assay was performed in a similar outline laid out by Biswas and Rather
[3]. Frozen cultures of the Acinetobacter baumannii mutants were collected and streaked for
DEAL, JUSTIN COLLIER
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isolation onto lysogeny broth plates. Overnight growth cell culture was collected and washed in
one milliliter of water three times by centrifugation. Cultures were then place into cuvettes,
optical density measured at 600 nm, and samples were diluted to 1.0 optical density. From there,
10 microliters of each sample was placed into their respective wells on a 96 well plate in
triplicate. The 96 well plate was then incubated at 37o Celsius until the water had evaporated,
then plates were transferred to 25°C. After two days, samples were resuspended in 200
microliters of lysogeny broth through a well plate shaker. From there, fivefold dilutions took
place in neighboring wells that contained phosphate-buffered saline. Once dilutions were
completed, seven microliter droplets were collected from the dilutions and transferred onto dried
petri dishes. The plates were allowed to sit at room temperature and colonies were allowed to
grow at 37oC until countable. Colonies were then counted and recorded as shown in the results
section. This was done on both inoculum samples as well as day 2 samples.
RESULTS
Once the data was collected, it came to light that some of the mutants were not properly
diluted on the inoculum day as planned in the materials and methods section. Therefore, final
values were not adjusted to this inoculum count. The raw colony-forming unit per milliliter
values were calculated for each particular mutant. They were then converted into a Log10 and put
through the ANOVA test to determine statistical significance. Everything was then converted to
the relevance of the wild type whose survival rate was set to 100% in order to compare the
mutants’ survival to what was expected of the wild type data. Our negative control Escherichia
coli wild type is also present within the graph (Figure 8).
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Figure 8: Percent Relative Survival where E. coli wild type is used as a negative control. A baumannii mutants
1221, 2135, 2255, and 3354 show statistical significance.

DISCUSSION
Desiccation assay:
Mutant 2255 has shown significance in both the desiccation assay as well as the motility
assay. This can be speculated that by hindering motility survivability decreases under
desiccation. This could be a failure to sense a surface, failure to adhere to the plastic, or send
signals to stimulate the pilus interaction needed. This can even be extended to 1221 since it also
showed a phenotypic change within the twitching motility assay. However, 1221 shows
increased survivability. In the case of 2135, it can be hypothesized that deleting this gene, which
is a diguanylate cyclase domain, can decrease concentration of cyclic di-GMP. By decreasing the
concentration of this second messenger molecule, survivability under desiccation increases. As
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seen before, knocking out the genes within 3354 not only increases survivability, but it also
decreased the amount of biofilm A. baumannii produced. 3354 and 1221 are interesting mutants
to show significance because they show to have both a diguanylate cyclase and the
phosphodiesterase protein domains. 1221 one and 3354 shows increased survivability. This can
be argued that in this instance they act as DGCs. This can be a complicated matter and leads us
to the future steps of the experiment.
For the future:
It is clear from this series of results that more research needs to be done to completely
understand the role of cyclic di-GMP in Acinetobacter baumannii. An additional test that can be
done with the multi-drug resistant strain 5075 is to perform an assay that accounts for
concentrations of cyclic di-GMP within the cell. Mutants of 3354 and 1221 would need
mutations in one of the active site domains at a time to determine which domain is responsible
for motility, biofilm formation, and increased survivability in the desiccation assay. In
continuation, complementation tests of the biofilm, twitching motility, antibiotic resistance, and
desiccation assays will need to be conducted to ensure that deletion of these genes is responsible
for the phenotypes. Further, direct measurement of concentrations of cyclic di-GMP need to
performed, and these assays can be replicated in a second strain of A. baumannii to determine
whether these phenotypes are conserved within other Acinetobacter strains. By designing these
mutants and performing the series of experiments laid out, a more cohesive answer will emerge
on how these different genes play a role in virulence.
CONCLUSION
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Acinetobacter baumannii is a multi-drug resist bacterium that is responsible for
nosocomial infections in patients by residing on plastics and hard surfaces through biofilms. The
rising risk of superbugs that have grown resistance to an array of antibiotics is a growing concern
in modern day medicine. It has been shown that the second messenger molecule, cyclic di-GMP,
can control virulence factors, such as biofilm formation. The experimentation that has been done
so far has shown that cyclic di-GMP does show means of controlling virulence factors within
Acinetobacter baumannii. This shows promise in combating this multi-drug resistant bacterium
and needs further research to be more conclusive on the exact mechanisms that are taking place.
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